跳至主要内容
临床试验/NL-OMON56983
NL-OMON56983尚未招募不适用

nderstanding the Pathophysiology of metabolic dysfunction-associated steatotic liver disease and Metabolic Syndrome Following Cholecystectomy* - Long-term metabolic consequences cholecystectomy

Radboud Universitair Medisch Centrum0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patients referred to a surgeon with abdominal complaints and ultrasound
  • proven gallstones or sludge (proven before or after referral) subjected to a
  • laparoscopic cholecystectomy or conservative treatment
  • Availability of informed consent.
  • Age 30-60 years

排除标准

  • Patients with pre-operative signs of complicated gallstone disease
  • (cholecystitis, choledocholithiasis, cholangitis, pancreatitis),
  • Signs of cholestasis requiring intervention (e.g. Endoscopisch Retrograde
  • Cholangio- en Pancreaticografie)
  • ASA score III (patient with severe systemic disease (e.g. morbid obesity,
  • renal failure) or IV (patient with severe systemic disease that is a constant
  • threat to life)
  • Malignancy (excluding skin malignancies: basal cell carcinoma and
  • non-metastatic squamous cell carcinoma)
  • History after bariatric surgery or expected bariatric procedure within 2
  • History of inflammatory bowel disease.
  • History of alcohol abuse (man >3 and women >2 glasses per day)
  • Liver disease (i.e. (autoimmune hepatitis)
  • Use steatogenic medication (i.e., methotrexate, tamoxifen, amiodarone, and
  • systemic corticosteroids)
  • Use of DPP4-inhibitors
  • Diabetes mellitus
  • Use of antibiotics in the previous 3 months
  • Gastro-intestinal surgery in the previous 3 months
  • Stoma (small bowel or colon)
  • Patients that are lactose intolerant / allergic to dairy
  • Known anaemia < 6 mmol/l
  • Expected short life span of less than 12 months
  • - Body Mass Index (BMI) >30

研究者

相似试验

nderstanding the Pathophysiology of metabolic... | 临床试验